Avantor, Inc. (NYSE:AVTR) Shares Purchased by D. E. Shaw & Co. Inc.

D. E. Shaw & Co. Inc. boosted its position in Avantor, Inc. (NYSE:AVTR - Free Report) by 864.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 298,572 shares of the company's stock after purchasing an additional 267,622 shares during the period. D. E. Shaw & Co. Inc.'s holdings in Avantor were worth $6,291,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB raised its holdings in shares of Avantor by 99.5% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company's stock worth $26,000 after buying an additional 625 shares during the period. Smartleaf Asset Management LLC grew its position in Avantor by 106.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company's stock valued at $34,000 after acquiring an additional 830 shares during the last quarter. Global Retirement Partners LLC increased its stake in Avantor by 76.7% in the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company's stock worth $52,000 after purchasing an additional 1,067 shares during the period. UMB Bank n.a. lifted its position in shares of Avantor by 56.3% during the fourth quarter. UMB Bank n.a. now owns 2,981 shares of the company's stock worth $63,000 after purchasing an additional 1,074 shares during the last quarter. Finally, AlphaQuest LLC bought a new stake in shares of Avantor during the fourth quarter worth $65,000. Institutional investors own 95.08% of the company's stock.

Avantor Stock Up 1.1%

NYSE:AVTR traded up $0.14 during trading hours on Thursday, reaching $12.69. The company's stock had a trading volume of 1,754,453 shares, compared to its average volume of 7,837,821. The stock has a 50 day moving average price of $14.59 and a two-hundred day moving average price of $18.42. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.70 and a current ratio of 1.07. The company has a market capitalization of $8.64 billion, a P/E ratio of 12.19, a price-to-earnings-growth ratio of 1.55 and a beta of 1.09. Avantor, Inc. has a 12 month low of $11.82 and a 12 month high of $28.00.

Avantor (NYSE:AVTR - Get Free Report) last released its quarterly earnings results on Friday, April 25th. The company reported $0.23 EPS for the quarter, hitting the consensus estimate of $0.23. The firm had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.61 billion. Avantor had a return on equity of 12.17% and a net margin of 10.49%. The business's revenue for the quarter was down 5.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.22 EPS. Equities analysts predict that Avantor, Inc. will post 1.06 EPS for the current fiscal year.

Insider Buying and Selling at Avantor

In other news, EVP James Bramwell sold 3,758 shares of the business's stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total transaction of $65,877.74. Following the sale, the executive vice president now directly owns 87,379 shares of the company's stock, valued at $1,531,753.87. The trade was a 4.12% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Steven W. Eck sold 4,907 shares of the firm's stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $86,019.71. Following the completion of the transaction, the chief accounting officer now owns 40,604 shares of the company's stock, valued at approximately $711,788.12. The trade was a 10.78% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.20% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the stock. Barclays reduced their price target on shares of Avantor from $18.00 to $15.00 and set an "overweight" rating on the stock in a research note on Monday, April 28th. Cowen lowered shares of Avantor from a "buy" rating to a "hold" rating in a research report on Monday, April 28th. Citigroup decreased their price target on shares of Avantor from $22.00 to $18.00 and set a "neutral" rating for the company in a research note on Tuesday, March 4th. TD Cowen lowered Avantor from a "buy" rating to a "hold" rating and set a $15.50 price target for the company. in a report on Monday, April 28th. Finally, Royal Bank of Canada reduced their price objective on Avantor from $24.00 to $20.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. Seven equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $18.88.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.